Gilead Wins Reversal of $2.54 Billion Hepatitis C Drug Patent Verdict

  1. Gilead Wins Reversal of $2.54 Billion Hepatitis C Drug Patent Verdict  P&T Community

  2. US judge overturns Gilead $2.54bn patent infringement ruling  pharmaphorum
  3. US court voids $2.5 billion verdict in Gilead/Merck patent dispute  The Pharma Letter

    4. Full coverage